Christina Vicidomini is a Brooklyn, New York based female Ophthalmologist who is specialized in Ophthalmology. Active license number of Christina Vicidomini is 301808 for Ophthalmology in New York. Christina Vicidomini is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Christina Vicidomini speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Gender:
Female
Practice Address:
450 Clarkson Ave, Brooklyn, New York, 11203-2012
Phone:
718-270-1584
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1962902304
NPI Enumeration Date:
12 Feb, 2018
NPI Last Update On:
30 Aug, 2022
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Christina Vicidomini are as mentioned below.
License Number
Specialization
State
Status
301808
Ophthalmology
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2407 Ditmars Blvd Apt 2, Astoria, New York
Zip:
11105-3337
Phone Number:
347-236-5704
Fax Number:
--
Patients can reach Christina Vicidomini at 450 Clarkson Ave, Brooklyn, New York or can call to book an appointment on 718-270-1584. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.